SCHEMBL3799188

SCHEMBL3799188

COC(C=O)(OC)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790682 0.81
SCHEMBL21272283 0.78
SCHEMBL7931047 0.78
SCHEMBL22230195 0.78
SCHEMBL5053391 0.78
SCHEMBL25324988 0.67
SCHEMBL8059363 0.63
SCHEMBL20574085 0.60
SCHEMBL1321075 0.60
SCHEMBL8808070 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2052043-B1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO LTD (KR) 2016-10-12 EP disclosed
EP-2752470-A1 Process for preparation of silver nanoparticles, and the compositions of silver ink containing the same Inktec Co., Ltd. (KR) 2014-07-09 EP disclosed
US-8282860-B2 Process for preparation of silver nanoparticles, and the compositions of silver ink containing the same INKTEC CO., LTD. (KR) 2012-10-09 US disclosed
US-20100189901-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO., LTD. (KR) 2010-07-29 US disclosed
EP-2052043-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME Inktec Co., Ltd. (KR) 2009-04-29 EP disclosed
WO-2008018718-A1 PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME INKTEC CO., LTD. (KR) 2008-02-14 WO disclosed
US-6600036-B2 Treating diseases of the central nervous system. SCHERING AKTIENGESELLSCHAFT (DE) 2003-07-29 US disclosed
US-20020052364-A1 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2002-05-02 US disclosed
US-6323197-B1 NON-COMPETITIVE INHIBITING OF THE AMPA RECEPTORS, THESE COMPOUNDS CAN BE USED AS MEDICAMENTS FOR TREATMENT OF THE CENTRAL NERVOUS SYSTEM SCHERING AKTIENGESELLSCHAFT (DE) 2001-11-27 US disclosed